Literature DB >> 21073327

Toll-like receptor 3: involvement with exogenous and endogenous RNA.

Marla Karine Amarante1, Maria Angelica Ehara Watanabe.   

Abstract

The recognition of pathogens is assigned to an evolutionarily conserved family of receptors, the Toll-like receptors (TLRs). The investigation of RNA-based immunology has been reinvigorated with the observation that TLR3s interact with RNA (dsRNA of viral origin, poly (I:C) and endogenous RNA). Many RNAs, therefore, join the list of endogenous ligands for TLRs. The further finding that nucleoside modification alters RNA-mediated TLR signaling presents a mechanism for the long-observed differences in immunogenicity. The involvement of RNA modification in the pathogenesis of diseases, and its implications in the therapeutics, are still being studied, and will have important implications in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073327     DOI: 10.3109/08830185.2010.525723

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  16 in total

1.  Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.

Authors:  Marla Karine Amarante; Karen Brajão de Oliveira; Roberta Losi Guembarovski; Ana Cristina da Silva do Amaral Herrera; Alda Losi Guembarovski; Walter Jorge Sobrinho; Julio Cesar Voltarelli; Maria Angelica Ehara Watanabe
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

2.  Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3.

Authors:  Marla Karine Amarante; Julie Massayo Maeda Oda; Edna Maria Vissoci Reiche; Helena Kaminami Morimoto; Mateus Nobrega Aoki; Maria Angelica Ehara Watanabe
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

Review 3.  Mouse models of gene-environment interactions in schizophrenia.

Authors:  Geetha Kannan; Akira Sawa; Mikhail V Pletnikov
Journal:  Neurobiol Dis       Date:  2013-06-05       Impact factor: 5.996

Review 4.  Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine.

Authors:  Yan-Lin Guo; Gordon G Carmichael; Ruoxing Wang; Xiaoxiao Hong; Dhiraj Acharya; Faqing Huang; Fengwei Bai
Journal:  Stem Cells       Date:  2015-07-06       Impact factor: 6.277

5.  Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA.

Authors:  Ruoxing Wang; Jundi Wang; Amber M Paul; Dhiraj Acharya; Fengwei Bai; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

6.  Polyinosinic-polycytidylic acid inhibits the differentiation of mouse preadipocytes through pattern recognition receptor-mediated secretion of tumor necrosis factor-α.

Authors:  Lili Yu; Guoyan Liu; Can Yang; Xiangfeng Song; Hui Wang
Journal:  Immunol Cell Biol       Date:  2016-06-17       Impact factor: 5.126

7.  Double-stranded RNA upregulates the expression of inflammatory mediators in human aortic valve cells through the TLR3-TRIF-noncanonical NF-κB pathway.

Authors:  Qiong Zhan; Rui Song; Fei Li; Lihua Ao; Qingchun Zeng; Dingli Xu; David A Fullerton; Xianzhong Meng
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-04       Impact factor: 4.249

Review 8.  The danger model approach to the pathogenesis of the rheumatic diseases.

Authors:  César Pacheco-Tena; Susana Aideé González-Chávez
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

9.  Activation of TLR3 induces osteogenic responses in human aortic valve interstitial cells through the NF-κB and ERK1/2 pathways.

Authors:  Qiong Zhan; Rui Song; Qingchun Zeng; Qingzhou Yao; Lihua Ao; Dingli Xu; David A Fullerton; Xianzhong Meng
Journal:  Int J Biol Sci       Date:  2015-03-20       Impact factor: 6.580

10.  Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients.

Authors:  Houssein El-Saghire; Charlot Vandevoorde; Piet Ost; Pieter Monsieurs; Arlette Michaux; Gert De Meerleer; Sarah Baatout; Hubert Thierens
Journal:  Int J Oncol       Date:  2014-01-17       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.